DLL4 and neoplasm: This approach has been demonstrated through the use of gold nanorod-locked nucleic acid (GNR-LNA) biosensors to examine Delta-like ligand 4 (DLL4) expression in a bladder cancer invasion model to reveal that DLL4 expression is upregulated at the invading front of tumor spheroids [92].